메뉴 건너뛰기




Volumn 30, Issue 3, 2007, Pages 491-493

Etanercept and pregnancy;Etanercept y embarazo

Author keywords

Arthritis; Etanercept; Pregnancy

Indexed keywords

ETANERCEPT;

EID: 38349133634     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (7)
  • 1
    • 33746985526 scopus 로고    scopus 로고
    • Are we coming to terms with Tumor Necrosis Factor inhibition in pregnancy?
    • SALMON JE, ALPERT D. Are we coming to terms with Tumor Necrosis Factor inhibition in pregnancy? Arthritis Rheumatism 2006; 54: 2353-2355.
    • (2006) Arthritis Rheumatism , vol.54 , pp. 2353-2355
    • SALMON, J.E.1    ALPERT, D.2
  • 2
    • 33646443354 scopus 로고    scopus 로고
    • Tumor necrosis factor-alfa inhibition and VATER association: A causal relationship?
    • CARTER J, VALERIANO J, VASEY FB. Tumor necrosis factor-alfa inhibition and VATER association: A causal relationship? J Rheumatol 2006; 33: 5: 1014-1017.
    • (2006) J Rheumatol , vol.33 , Issue.5 , pp. 1014-1017
    • CARTER, J.1    VALERIANO, J.2    VASEY, F.B.3
  • 3
    • 34047178478 scopus 로고    scopus 로고
    • Pregnancy in rheumatology patients exposed to anti-tumor necrosis factor(TNF)-alfa therapy
    • ROUX CH; BROCQ O, BREUIL V, ALBERT C, EULLER-ZIEGLER L. Pregnancy in rheumatology patients exposed to anti-tumor necrosis factor(TNF)-alfa therapy. Rheumatology (Oxford) 2007; 46: 695-698.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 695-698
    • ROUX, C.H.1    BROCQ, O.2    BREUIL, V.3    ALBERT, C.4    EULLER-ZIEGLER, L.5
  • 4
    • 33750522009 scopus 로고    scopus 로고
    • Rheumatoid arthritis in pregnancy: Successful outcome with anti-TNF agent(Etanercept)
    • SINHA A, PATIENT CJ. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent(Etanercept). Obstet Gynaecol 2006; 26: 689-691.
    • (2006) Obstet Gynaecol , vol.26 , pp. 689-691
    • SINHA, A.1    PATIENT, C.J.2
  • 5
    • 33845968087 scopus 로고    scopus 로고
    • Efficacy and safety of etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
    • MICHELOUD D, NUÑO L, RODRÍGUEZ- MAHOU M, SÁNCHEZ-RAMÓN S, ORTEGA MC, AQUARÓN A et al. Efficacy and safety of etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy. Lupus 2006; 15: 881-885.
    • (2006) Lupus , vol.15 , pp. 881-885
    • MICHELOUD, D.1    NUÑO, L.2    RODRÍGUEZ- MAHOU, M.3    SÁNCHEZ-RAMÓN, S.4    ORTEGA, M.C.5    AQUARÓN, A.6
  • 6
    • 34047178478 scopus 로고    scopus 로고
    • Pregnancy in rheumatology patients exponed to anti-tumor necrosis factor (TNF-alpha) therapy
    • ROUX CH, BROCQ O, BREUIL V, ALBERT C, EULLER-ZIEGLER L. Pregnancy in rheumatology patients exponed to anti-tumor necrosis factor (TNF-alpha) therapy. Rheumatology (Oxford) 2007; 46: 695-698.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 695-698
    • ROUX, C.H.1    BROCQ, O.2    BREUIL, V.3    ALBERT, C.4    EULLER-ZIEGLER, L.5
  • 7
    • 34548281182 scopus 로고    scopus 로고
    • Pregnancy in rheumatology patients exposed to antitumour necrosis factor (TNF)-alfa therapy
    • ROSNER I, HADDAD A, BOULMAN N, FELD J, AVSHOVICH N, SLOBODIN G et al. Pregnancy in rheumatology patients exposed to antitumour necrosis factor (TNF)-alfa therapy. Rheumatology 2007; 46: 1508-1509.
    • (2007) Rheumatology , vol.46 , pp. 1508-1509
    • ROSNER, I.1    HADDAD, A.2    BOULMAN, N.3    FELD, J.4    AVSHOVICH, N.5    SLOBODIN, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.